Results 11 to 20 of about 11,725 (285)

Ionizable Lipid Nanoparticles for mRNA Delivery

open access: yesAdvanced NanoBiomed Research, 2023
Therapeutics based on messenger RNA (mRNA) have become a promising class of methods for various diseases’ treatments in recent years. The safe and effective delivery of mRNA into target cells is the premise of the clinical translation of mRNA. Due to the
Xuefeng Tang, Ying Zhang, Xiaojun Han
doaj   +2 more sources

Modulating the Nature of Ionizable Lipids and Number of Layers in Hyaluronan-Decorated Lipid Nanoparticles for In Vitro Delivery of RNAi [PDF]

open access: yesPharmaceutics
Lipid nanoparticles (LNPs) have established their position as nonviral vectors for gene therapy. Tremendous efforts have been made to modulate the properties of LNPs to unleash their full clinical potential.
Victor Passos Gibson   +6 more
doaj   +2 more sources

Spotlighting the criticality of lipid quality control through a mechanistic investigation of mRNA activity loss in lipid nanoparticles [PDF]

open access: yesCommunications Chemistry
Lipid nanoparticles (LNPs) have gained much attention after the recent launch of mRNA based Covid vaccines. For mRNA encapsulated within LNPs to be successfully translated into target proteins, the mRNA must maintain its integrity and also be free of any
Richard S. Kang   +5 more
doaj   +2 more sources

Carbon dot-lipidoid nanocarriers for superiorly biocompatible nasal mRNA cancer vaccination [PDF]

open access: yesJournal of Nanobiotechnology
In this study, we synthesized an ionizable lipidoid, Cdoids, composed of carbon dots (Cdots) conjugated with oleic acid that exhibits superior biocompatibility compared to conventional ionizable lipids while retaining intrinsic fluorescence for real-time
Hongjae Kim   +7 more
doaj   +2 more sources

Substituting racemic ionizable lipids with stereopure ionizable lipids can increase mRNA delivery. [PDF]

open access: yesJ Control Release, 2023
Lipid nanoparticles (LNPs) have delivered siRNA and mRNA drugs in humans, underscoring the potential impact of improving the therapeutic window of next-generation LNPs. To increase the LNP therapeutic window, we applied lessons from small-molecule chemistry to ionizable lipid design.
Da Silva Sanchez AJ   +11 more
europepmc   +3 more sources

An ionizable lipid toolbox for RNA delivery [PDF]

open access: yesNature Communications, 2021
Recent years have witnessed incredible growth in RNA therapeutics, which has benefited significantly from decades of research on lipid nanoparticles, specifically its key component—the ionizable lipid. This comment discusses the major ionizable lipid types, and provides perspectives for future development.
Xuexiang Han   +6 more
openaire   +4 more sources

Boosting ribosomal translation via ionizable lipid-hydrogel microplexes for localized mRNA therapy [PDF]

open access: yesBioactive Materials
mRNA therapy holds immense promise for regenerative medicine; however, localized endoplasmic reticulum stress (ERS) in damaged tissues can impair the critical process of ribosomal translation.
Yanyang Chen   +7 more
doaj   +2 more sources

Branching Ionizable Lipids Can Enhance the Stability, Fusogenicity, and Functional Delivery of mRNA [PDF]

open access: yesSmall Science, 2023
Kazuki Hashiba   +9 more
doaj   +3 more sources

Calculating Apparent pKa Values of Ionizable Lipids in Lipid Nanoparticles. [PDF]

open access: yesMol Pharm
Creating new ionizable lipids for use in lipid nanoparticles (LNPs) is an active field of research. One of the critical properties for selecting suitable ionizable lipids is the apparent pKa value of the lipid as formulated in an LNP. We have developed a structure-based, computational methodology for the prediction of the apparent pKa value of ...
Hamilton NB   +4 more
europepmc   +3 more sources

mRNA vaccine developed for sequential selective organ-to-cell targeting of glioma [PDF]

open access: yesNature Communications
Messenger RNA (mRNA)-based therapeutics hold great potential for effectively treating various diseases. However, the targeting of mRNA delivered by systemically administered lipid nanoparticles (LNP) is currently limited to the liver.
Lin Shi   +7 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy